Delivery Order SPE2DB20D3103-SPE2DB23FP8R1

Award Date 9/25/23
Potential Completion Date 9/26/23
Potential Value $17
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $30,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 milligram/50 milliliter vials of cisplatin, a chemotherapy drug. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The delivery order has a period of performance from July 14, 2023 through July 17, 2023. No subcontractors or set aside designations were specified. The Defense Logistics Agency manages the Department of Defense's global...
The Defense Logistics Agency awarded a $30,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 milligram/50 milliliter vials of cisplatin, a chemotherapy drug. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The delivery order has a period of performance from July 14, 2023 through July 17, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the Department of Defense's global...
The Defense Logistics Agency awarded a $30,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 milligram/50 milliliter vials of cisplatin, a chemotherapy drug. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The delivery order has a period of performance from July 14, 2023 through July 17, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency manages the Department of Defense's...
The Defense Logistics Agency awarded a $30,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 milligram/50 milliliter vials of cisplatin, a chemotherapy drug. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The delivery order has a period of performance from July 14, 2023 through July 17, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency manages the Department of Defense's...
The Defense Logistics Agency awarded a $30,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 milligram/50 milliliter vials of cisplatin, a chemotherapy drug. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The delivery order has a period of performance from July 14, 2023 through July 17, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency manages the Department of Defense's...
The Defense Logistics Agency awarded a $40,300 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 milliliter vials of cisplatin 100 milligram/100 milliliter. The place of performance is Conshohocken, Pennsylvania. The period of performance is July 5-6, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, and this delivery order for the chemotherapy drug cisplatin supports the Agency's mission to provide...
The Defense Logistics Agency awarded a $30,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 milligram/50 milliliter vials of cisplatin, a chemotherapy drug. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The delivery order has a period of performance from July 14, 2023 through July 17, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency manages the Department of Defense's...
The Defense Logistics Agency awarded a $40,300 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 milliliter vials of cisplatin 100 milligram/100 milliliter. The place of performance is Conshohocken, Pennsylvania. The period of performance is one day, from June 29, 2023 to June 30, 2023. The Defense Logistics Agency manages the Department of Defense's global supply chain and is responsible for procuring pharmaceuticals and medical supplies to support military treatment...
The Defense Logistics Agency awarded a $30,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 milligram/50 milliliter vials of cisplatin, a chemotherapy drug. The delivery order was issued against an existing prime vendor contract vehicle and calls for Amerisourcebergen to provide 4561500658 vials of cisplatin from its facility in Conshohocken, Pennsylvania for delivery between July 14-17, 2023. No subcontractors or set aside designations were identified. The...
The Defense Logistics Agency awarded a $30,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 milligram/50 milliliter vials of cisplatin, a chemotherapy drug. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on July 14, 2023 and ending on July 17, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency procures and...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP8R1
    Delivery Order

The Defense Logistics Agency awarded a $17,450 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 milliliter vials of cisplatin 100 milligram/100 milliliter. Performance will take place in Conshohocken, Pennsylvania from September 25-26, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, and this delivery order for chemotherapy drugs will likely support DLA's pharmaceutical programs that supply medical treatment facilities. No set aside designation or subcontractors were indicated.

Generated 12/25/23, 10:06 AM